Approved revisions

View list of: Pages whose approved revision is not their latest | Unapproved pages | All pages with an approved revision | Pages with invalid approvals

Showing below up to 50 results in range #101 to #150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. 12. Laboratory analysis of plasma proteins (revision 4052, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  2. 12. Palliative care (revision 5007, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  3. 12. Proteins in blood and blood clotting (revision 1576, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  4. 12. Screening of malignant diseases (revision 3484, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  5. 12. Systemic amyloidosis (revision 575, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  6. 12. Urea cycle and ammonium metabolism (revision 1382, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  7. 120. Ergonomic factors. Health effects of inorganic and organic dusts and their prevention (revision 1194, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  8. 121. New and emerging risks in occupational medicine. Occupational diseases of health care workers and prevention. Occupational accidents. (revision 1195, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  9. 122. Migration and catastrophes, medical and occupational health considerations (revision 1196, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  10. 12A. Encephalitis (revision 2232, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  11. 12B. Primary prevention of stroke (revision 2233, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  12. 12 – Acute injuries and degenerative diseases of the knee joint (revision 5201, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  13. 13. Acoustic tumours, noise induced hearing losses (revision 3085, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  14. 13. Amino acid metabolism; the fate of the carbon skeleton (revision 1384, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  15. 13. Calcification in breast cancer (Kossa reaction) (revision 4467, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  16. 13. Cholelithiasis, chronic cholecystitis and empyema (revision 4405, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  17. 13. Cholinergic agonists and cholinesterase inhibitors (revision 1984, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  18. 13. Chronic viral hepatitis (aetiology, types), pathomorphology and differential diagnostics, detection of virus associated antigens and their significance) (revision 65, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  19. 13. Clear cell carcinoma of the kidney (revision 4694, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  20. 13. Describe the intra- and extracellular ionic components and explain their physiological functions (revision 1222, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  21. 13. Development of the female genital organs. Malformations (revision 1653, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  22. 13. Effector functions of antibodies (revision 2802, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  23. 13. Endogenous non-hemoglobinogenic pigments. Lipofuscin, melanin, homogentizic acid (revision 232, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  24. 13. Epidemiology and prevention of lung cancer (revision 1158, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  25. 13. Evidence-based medicine and prevention (revision 1077, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  26. 13. Food safety, food safety testing (revision 1115, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  27. 13. Hypovolemic shock: Causes and hemodynamics (revision 1704, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  28. 13. Imaging of the esophagus, stomach and small bowels. Methods, indications, imaging strategy. (revision 3322, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  29. 13. Laboratory analysis of plasma enzymes (revision 4056, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  30. 13. Macronodular (postnecrotic) cirrhosis (revision 707, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  31. 13. Molecular mechanisms of blood pressure regulation (revision 1578, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  32. 13. Pathophysiology of chronic pancreatitis (revision 1860, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  33. 13. Tumors of head and neck (revision 5023, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  34. 13A. Ischias syndrome and cervicobrachialgia (symptoms, warning signs) (revision 5245, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  35. 13B. Clinical features of multiple sclerosis (revision 2235, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  36. 13 – Low back pain (revision 5215, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  37. 14. Cardiogenic shock: Causes and hemodynamics (revision 1705, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  38. 14. Chemoprevention (revision 1116, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  39. 14. Cirrhosis and hepatic failure (+ alcoholic and fatty liver disease) (revision 90, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  40. 14. Complement system (revision 1511, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  41. 14. Development of the male genital organs. Malformations (revision 1654, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  42. 14. Disorders of intermediary metabolism in general liver cell damage (revision 1861, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  43. 14. Disturbances of non-immunoglobulin plasma proteins (revision 4071, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  44. 14. Dystrophic and metastatic calcification. Organ manifestations (revision 235, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  45. 14. Epidemiology and prevention of colorectal cancer (revision 1159, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  46. 14. Focal nodular hyperplasia (revision 4632, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  47. 14. Gaucher’s disease (revision 4468, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  48. 14. History and objectives of epidemiology (revision 1078, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  49. 14. Imaging of the colon. Inflammatory diseases of the colon. Diverticulosis. Colon tumors. (revision 3380, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  50. 14. Lung cancer (revision 5026, approved by 127.0.0.1 on 26 November 2024 at 10:57)

View ( | ) (20 | 50 | 100 | 250 | 500)